1. HBW Insight
  2. >>Geography
  3. >>Europe

Serrix Strikes Deal With OTC Medical For Netherlands Distribution

 
• By David Ridley

OTC Medical is now the distributor in the Netherlands of Serrix’s self-care brands, including fungal nail brand Mycosan, zinc-based cold sore treatment SoreFiX and children’s skincare brand donttellmum.

Amsterdam-based Serrix has partnered with OTC Medical • Source: Shutterstock

Amsterdam-based consumer health firm Serrix BV has entered a strategic partnership with Dutch company OTC Medical BV to distribute its brands in the Netherlands.

Effective immediately, OTC Medical will oversee the distribution of Serrix’s self-care brands, including fungal nail range Mycosan, zinc-based cold sore

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Value Of Consumer Wearables Within The Clinic Currently Unknown, Says Cardiologist

 
• By Natasha Barrow

“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”

EU Parliament Calls For Review Of Wastewater Directive’s Impact On Pharma Sector

 
• By David Ridley

At a recent plenary session the European Parliament adopted a resolution calling on the European Commission to “conduct a new and comprehensive assessment” of the impact of the revised Urban Wastewater Treatment Directive on the pharmaceutical sector.

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By David Ridley

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”

US Tariffs Pose ‘Existential Threat’ To EU Medical Devices Industry

 
• By David Ridley

AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.

More from Startups & SMEs

UK’s Maxwellia Looking For £2m Investment To Fuel ‘Next Phase Of Rapid Growth’

 
• By David Ridley

Maxwellia is inviting 100 investors to contribute to the “development of new healthcare solutions that will benefit millions, while also playing a role in shaping the future of self-care.”

‘Inside Regulatory Affairs’ With AdverCheck’s Lucy Rochford And James Walmsley

 
• By HBW Insight Team and Nancy Pham

In this instalment of HBW Insight’s “Inside Regulatory Affairs” series, AdverCheck managing directors Lucy Rochford and James Walmsley describe how the consumer health industry is increasingly outsourcing its advertising copy review as it moves closer to the fast-moving consumer goods sector. They also point to a worrying trend in the UK of advertising prescription-only medicines online.

US Eroxon Launch In October Will Mark Haleon’s First Foray Into Sexual Health

 
• By David Ridley

Haleon will launch Futura Medical's FDA-approved OTC medical device for erectile dysfunction in the US before the end of the year. Already available to pre-order online on Amazon, Eroxon represents the firm's first move into the sexual health category.